BTAI - BioXcel Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
BioXcel Therapeutics, Inc.
IPO Date: March 5, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $2.31M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.62 | 4.83%
Avg Daily Range (30 D): $0.09 | 23.80%
Avg Daily Range (90 D): $0.06 | 7.25%
Institutional Daily Volume
Avg Daily Volume: 1.17M
Avg Daily Volume (30 D): 10.37M
Avg Daily Volume (90 D): 4.12M
Trade Size
Avg Trade Size (Sh.): 178
Avg Trade Size (Sh.) (30 D): 1,018
Avg Trade Size (Sh.) (90 D): 785
Institutional Trades
Total Institutional Trades: 917
Avg Institutional Trade: $1.44M
Avg Institutional Trade (30 D): $.87M
Avg Institutional Trade (90 D): $.87M
Avg Institutional Trade Volume: .01M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.56M
Avg Closing Trade (30 D): $.87M
Avg Closing Trade (90 D): $.87M
Avg Closing Volume: 4.6K
 
News
Aug 31, 2026 @ 3:36 PM
Teva Seeks to Boost Neuroscience Portfolio With Bi...
Source: Na
Jul 21, 2026 @ 9:00 PM
[Latest] Global AI in Drug Repurposing Market Size...
Source: Healthcare Foresights
Mar 23, 2026 @ 12:00 PM
Levi & Korsinsky, LLP Announces Proposed Class Act...
Source: Levi & Korsinsky, Llp
Mar 10, 2026 @ 6:36 PM
BioXcel Therapeutics Announces Approximately $8.0 ...
Source: Bioxcel Therapeutics, Inc.
Oct 13, 2025 @ 11:00 AM
BioXcel Therapeutics to Ring Nasdaq Closing Bell o...
Source: Vimal Mehta, Ph.D.
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-2.55 $-.49 $-.54
Diluted EPS $-2.55 $-.49 $-.54
Revenue $.74M $.18M $.21M
Gross Profit $.39M $.16M $-.08M
Net Income / Loss $-70.86M $-14.71M $-12.69M
Operating Income / Loss $-44.93M $-10.19M $-10.22M
Cost of Revenue $.35M $.02M $.28M
Net Cash Flow $M $M $M
PE Ratio    
Splits
Feb 10, 2025 1:16